PPA
KBIO

Parametric Portfolio Associates’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Parametric Portfolio Associates’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,663
Closed -$21K – 4096
2014
Q3 		$21K Buy
+1,663
New +$22.9K ﹤0.01% 3797
2014
Q2 		– Sell
-5,347
Closed -$116K – 3948
2014
Q1 		$116K Buy
+5,347
New +$155K ﹤0.01% 3729

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SIM
SSI Investment Management Los Angeles, California $1.45B AUM 5.8% 1-Year Est. Return

Parametric Portfolio Associates's KBIO Position: Q4 2014 in Review

Parametric Portfolio Associates sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q4 2014, closing a stake of 1,663 shares — an estimated $21K sold.

Parametric Portfolio Associates first reported a position in KBIO in Q1 2014 and held it in 2 quarters. The position peaked at $116K in Q1 2014. 36 funds tracked by Wall St. Rank hold KBIO as of Q4 2014.

  • Parametric Portfolio Associates reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q4 2014 after selling out during the quarter.
  • Parametric Portfolio Associates sold 1,663 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q4 2014, an estimated $21K.
  • Parametric Portfolio Associates first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q1 2014 and held it in 2 quarters.
  • Parametric Portfolio Associates's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $116K in Q1 2014.
  • 36 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q4 2014.

Based on Parametric Portfolio Associates's 13F filing for Q4 2014, filed 11 Feb 2015.